Prostanoids for critical limb ischaemia-Reference-Cited by-同舟云学术

Prostanoids for critical limb ischaemia

Published:2018-01-10 Issue:1 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Vietto Valeria¹²,Franco Juan VA²,Saenz Victoria³,Cytryn Denise¹,Chas Jose⁴,Ciapponi Agustín⁵

Affiliation:

1. Hospital Italiano de Buenos Aires; Family and Community Medicine Service; Buenos Aires Argentina

2. Instituto Universitario Hospital Italiano; Argentine Cochrane Centre; Buenos Aires Argentina

3. Unidad Asistencial Dr. César Milstein; Internal Medicine; La Rioja 951 Ciudad Autónoma de Buenos Aires Buenos Aires Argentina C1221ACI

4. Hospital Italiano de Buenos Aires; Cardiovascular Surgery Department; Buenos Aires Argentina Perón 4190

5. Institute for Clinical Effectiveness and Health Policy (IECS-CONICET); Argentine Cochrane Centre; Dr. Emilio Ravignani 2024 Buenos Aires Capital Federal Argentina C1414CPV

Publisher

Wiley

Subject

Pharmacology (medical)

Reference112 articles.

1. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study;Altstaedt;Prostaglandins Leukotrienes Essential Fatty Acids,1993

2. Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprost;Balzer;International Angiology,1991

3. Analysis of side effects of prostanoid-based treatment in patients suffering from critical ischaemia of the lower limbs;Bandiera;Chronica Dermatologica,1995

4. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial;Belch;Lancet,1983

5. The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemia;Belch;International Angiology,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-06-11

2. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease;Journal of the American College of Cardiology;2024-06

3. Endovascular and Surgical Venous Arterialization for No-Option Patients With Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis;Journal of Endovascular Therapy;2023-11-27

4. Real-world effect of iloprost in patients with chronic limb-threatening ischemia (CLTI): A cohort study;Vascular Medicine;2023-11-07

5. Effects of iloprost in patients with critical limb ischemia: Results of a cohort study from the COPART registry;JMV-Journal de Médecine Vasculaire;2023-11